share_log

Elevai Labs | 8-K: Current report

Elevai Labs | 8-K: Current report

Elevai Labs | 8-K:重大事件
美股SEC公告 ·  2024/11/23 06:01

Moomoo AI 已提取核心信息

Elevai Labs Inc. announced a 1-for-200 reverse stock split effective November 27, 2024, to comply with Nasdaq's minimum bid price requirement of $1.00 per share. The split will consolidate every 200 shares of common stock into one share, with fractional shares rounded up to whole shares. The trading symbol remains "ELAB" but with a new CUSIP number.The company's equity incentive plan, outstanding stock awards, and options have been proportionally adjusted. Post-split, approximately 3.07 million shares of common stock will be outstanding. The move aims to maintain Elevai's Nasdaq listing, enhancing visibility and investor confidence.CEO Graydon Bensler stated that the reverse split is necessary to preserve the Nasdaq listing and position the company for continued progress. Shareholders holding shares through brokers require no action, while those with physical certificates can exchange them through VStock Transfer, LLC.
Elevai Labs Inc. announced a 1-for-200 reverse stock split effective November 27, 2024, to comply with Nasdaq's minimum bid price requirement of $1.00 per share. The split will consolidate every 200 shares of common stock into one share, with fractional shares rounded up to whole shares. The trading symbol remains "ELAB" but with a new CUSIP number.The company's equity incentive plan, outstanding stock awards, and options have been proportionally adjusted. Post-split, approximately 3.07 million shares of common stock will be outstanding. The move aims to maintain Elevai's Nasdaq listing, enhancing visibility and investor confidence.CEO Graydon Bensler stated that the reverse split is necessary to preserve the Nasdaq listing and position the company for continued progress. Shareholders holding shares through brokers require no action, while those with physical certificates can exchange them through VStock Transfer, LLC.
Elevai Labs Inc. 公布了一项1比200的反向股票拆分,生效日期为2024年11月27日,以符合纳斯达克每股至少1.00美元的买盘价格要求。该拆分将把每200股普通股合并为1股,碎股将向上取整为整股。交易标的保持为"ELAB",但会有一个新的CUSIP号码。公司的股权激励计划、未偿还股票奖励和期权已按比例调整。拆分后,约307万股普通股将会流通。此举旨在维持Elevai在纳斯达克的上市,提升可见度和投资者信心。首席执行官Graydon Bensler表示,进行反向股票拆分是为了保留纳斯达克的上市地位,并为公司持续发展做好准备。通过经纪商持股的股东无需采取行动,而持有实物股票证书的股东可以通过VStock Transfer, LLC进行兑换。
Elevai Labs Inc. 公布了一项1比200的反向股票拆分,生效日期为2024年11月27日,以符合纳斯达克每股至少1.00美元的买盘价格要求。该拆分将把每200股普通股合并为1股,碎股将向上取整为整股。交易标的保持为"ELAB",但会有一个新的CUSIP号码。公司的股权激励计划、未偿还股票奖励和期权已按比例调整。拆分后,约307万股普通股将会流通。此举旨在维持Elevai在纳斯达克的上市,提升可见度和投资者信心。首席执行官Graydon Bensler表示,进行反向股票拆分是为了保留纳斯达克的上市地位,并为公司持续发展做好准备。通过经纪商持股的股东无需采取行动,而持有实物股票证书的股东可以通过VStock Transfer, LLC进行兑换。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息